Oncostatin M

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

STABLE ANTI-OSMR ANTIBODY FORMULATION
EP 3609916 A1Applicant: KINIKSA PHARMACEUTICALS LTDPriority: 2017
CN
EP
US
WO
12 publications
Oncostatin M receptor antigen binding proteins
US 9663571 B2Applicant: KINIKSA PHARMACEUTICALS LTDPriority: 2013
CN
EP
US
8 publications
ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM)
EP 3211009 A1Applicant: GLAXO GROUP LTDPriority: 2010
EP
US
7 publications
ANTIBODIES TO CANINE AND FELINE ONCOSTATIN M RECEPTOR BETA AND USES THEREOF
EP 4229087 A1Applicant: ZOETIS SERVICES LLCPriority: 2020
CN
EP
US
WO
6 publications
Human Oncostatin M Antibodies and Methods of Use
US 2012093833 A1Applicant: ALMAGRO JUAN CARLOSPriority: 2011
US
6 publications
METHODS FOR TREATING PULMONARY FIBROTIC DISEASES OR DISORDERS WITH AN ANTI ONCOSTATIN M RECEPTOR BETA ANTIBODY
EP 4676966 A1Applicant: GENENTECH INCPriority: 2023
CN
EP
US
WO
4 publications
Immunoglobulins
- US 7858753 B2
  Applicant: GLAXO GROUP LTDPriority: 2004
  EP
  US
  4 publications
- CN 1997668 A
  Applicant: GLAXO GROUP LTDPriority: 2004
  CN
Treatment of hepatitis C with compositions comprising oncostatin M and interferon alpha
US 7829077 B2Applicant: PROYECTO BIOMEDICINA CIMA SLPriority: 2005
CN
US
4 publications
Antibodies to oncostatin M receptor
US 7572896 B2Applicant: RAVEN BIOTECHNOLOGIES INCPriority: 2006
US
4 publications
Systems and methods for making hepatocytes from extrahepatic somatic stem cells and use thereof
US 8062632 B2Applicant: LEE OSCAR KUANG-SHENGPriority: 2009
US
4 publications